Literature DB >> 22963989

Interactions between modafinil and cocaine during the induction of conditioned place preference and locomotor sensitization in mice: implications for addiction.

Tristan Shuman1, Denise J Cai, Jennifer R Sage, Stephan G Anagnostaras.   

Abstract

Modafinil is a wake-promoting drug effective at enhancing alertness and attention with a variety of approved and off-label applications. The mechanism of modafinil is not well understood but initial studies indicated a limited abuse potential. A number of recent publications, however, have shown that modafinil can be rewarding under certain conditions. The present study assessed the reinforcing properties of modafinil using conditioned place preference and locomotor sensitization in mice. Experiment 1 examined a high dose of modafinil (75 mg/kg) as well as its interactions with cocaine (15 mg/kg). Cocaine alone and modafinil co-administered with cocaine induced sensitization of locomotor activity; modafinil alone showed little or no locomotor sensitization. Animals given modafinil alone, cocaine alone, and modafinil plus cocaine exhibited a strong and roughly equivalent place preference. When tested for sensitization using a low challenge dose of modafinil, cross-sensitization was observed in all cocaine-pretreated mice. Experiment 2 examined a low dose of modafinil that is similar to the dose administered to humans and has been shown to produce cognitive enhancements in mice. Low dose modafinil (0.75 mg/kg) did not produce conditioned place preference or locomotor sensitization. Together, these results suggest that modafinil has the potential to produce reward, particularly in cocaine addicts, and should be used with caution. However, the typical low dose administered likely moderates these effects and may account for lack of addiction seen in humans.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22963989      PMCID: PMC4528911          DOI: 10.1016/j.bbr.2012.07.039

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  47 in total

Review 1.  Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

Authors:  John Grabowski; James Shearer; John Merrill; S Stevens Negus
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

Review 2.  Review. The incentive sensitization theory of addiction: some current issues.

Authors:  Terry E Robinson; Kent C Berridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

3.  Analysis of stimulant locomotor effects of modafinil in various strains of mice and rats.

Authors:  P Simon; C Hémet; J Costentin
Journal:  Fundam Clin Pharmacol       Date:  1996       Impact factor: 2.748

4.  Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers.

Authors:  L Ferraro; T Antonelli; W T O'Connor; S Tanganelli; F A Rambert; K Fuxe
Journal:  Biol Psychiatry       Date:  1997-12-15       Impact factor: 13.382

5.  Acute behavioral and physiological effects of modafinil in drug abusers.

Authors:  C R Rush; T H Kelly; L R Hays; R W Baker; A F Wooten
Journal:  Behav Pharmacol       Date:  2002-03       Impact factor: 2.293

6.  Modafinil-induced conditioned place preference via dopaminergic system in mice.

Authors:  Thi-Lien Nguyen; Yu-Hua Tian; In-Jee You; Seok-Yong Lee; Choon-Gon Jang
Journal:  Synapse       Date:  2011-03-28       Impact factor: 2.562

7.  Modafinil does not serve as a reinforcer in cocaine abusers.

Authors:  Suzanne K Vosburg; Carl L Hart; Margaret Haney; Eric Rubin; Richard W Foltin
Journal:  Drug Alcohol Depend       Date:  2009-09-23       Impact factor: 4.492

8.  Smoked cocaine self-administration is decreased by modafinil.

Authors:  Carl L Hart; Margaret Haney; Suzanne K Vosburg; Eric Rubin; Richard W Foltin
Journal:  Neuropsychopharmacology       Date:  2007-06-13       Impact factor: 7.853

9.  Enhancement of learning processes following an acute modafinil injection in mice.

Authors:  Daniel Béracochéa; Aurélie Celerier; Michel Peres; Christophe Pierard
Journal:  Pharmacol Biochem Behav       Date:  2003-12       Impact factor: 3.533

10.  Behavioral effects of modafinil in marmoset monkeys.

Authors:  Sanneke A M van Vliet; Marjan J Jongsma; Raymond A P Vanwersch; Berend Olivier; Ingrid H C H M Philippens
Journal:  Psychopharmacology (Berl)       Date:  2006-03-21       Impact factor: 4.415

View more
  12 in total

1.  Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration.

Authors:  Erin S Calipari; Sara R Jones
Journal:  Neuropharmacology       Date:  2014-03-13       Impact factor: 5.250

Review 2.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

3.  R-modafinil attenuates nicotine-taking and nicotine-seeking behavior in alcohol-preferring rats.

Authors:  Xiao-Fei Wang; Guo-Hua Bi; Yi He; Hong-Ju Yang; Jun-Tao Gao; Oluyomi M Okunola-Bakare; Rachel D Slack; Eliot L Gardner; Zheng-Xiong Xi; Amy Hauck Newman
Journal:  Neuropsychopharmacology       Date:  2015-01-23       Impact factor: 7.853

4.  Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.

Authors:  M Uguen; D Perrin; S Belliard; X Ligneau; P M Beardsley; J M Lecomte; J C Schwartz
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

5.  The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice.

Authors:  Maddalena Mereu; Lauren E Chun; Thomas E Prisinzano; Amy H Newman; Jonathan L Katz; Gianluigi Tanda
Journal:  Eur J Neurosci       Date:  2016-09-11       Impact factor: 3.386

Review 6.  Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Authors:  Suzanne Wood; Jennifer R Sage; Tristan Shuman; Stephan G Anagnostaras
Journal:  Pharmacol Rev       Date:  2013-12-16       Impact factor: 25.468

7.  Effects of modafinil and R-modafinil on brain stimulation reward thresholds: implications for their use in the treatment of psychostimulant dependence.

Authors:  Brian T Burrows; Lucas R Watterson; Meagan A Johnson; M Foster Olive
Journal:  J Drug Alcohol Res       Date:  2015-12-29

8.  Inhibition of PKC disrupts addiction-related memory.

Authors:  Kristin K Howell; Bradley R Monk; Stephanie A Carmack; Oliver D Mrowczynski; Robert E Clark; Stephan G Anagnostaras
Journal:  Front Behav Neurosci       Date:  2014-03-07       Impact factor: 3.558

9.  Modafinil Induces Rapid-Onset Behavioral Sensitization and Cross-Sensitization with Cocaine in Mice: Implications for the Addictive Potential of Modafinil.

Authors:  Raphael Wuo-Silva; Daniela F Fukushiro; André W Hollais; Renan Santos-Baldaia; Elisa Mári-Kawamoto; Laís F Berro; Thaís S Yokoyama; Leonardo B Lopes-Silva; Carolina S Bizerra; Roberta Procópio-Souza; Debora Hashiguchi; Lilian A Figueiredo; Jose L Costa; Roberto Frussa-Filho; Beatriz M Longo
Journal:  Front Pharmacol       Date:  2016-11-07       Impact factor: 5.810

Review 10.  Modafinil as a catecholaminergic agent: empirical evidence and unanswered questions.

Authors:  Jonathan Wisor
Journal:  Front Neurol       Date:  2013-10-07       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.